ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF263
|
ENSG00000006194.6 | ZNF263 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF263 | hg19_v2_chr16_+_3313791_3313834 | -0.61 | 1.2e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_102268628 | 9.49 |
ENST00000323055.6 ENST00000512215.1 ENST00000394854.3 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr19_-_51504852 | 6.74 |
ENST00000391806.2 ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8 |
kallikrein-related peptidase 8 |
chr8_-_49834299 | 6.49 |
ENST00000396822.1 |
SNAI2 |
snail family zinc finger 2 |
chr17_+_60704762 | 6.41 |
ENST00000303375.5 |
MRC2 |
mannose receptor, C type 2 |
chr8_-_49833978 | 6.10 |
ENST00000020945.1 |
SNAI2 |
snail family zinc finger 2 |
chr15_-_63674034 | 5.67 |
ENST00000344366.3 ENST00000422263.2 |
CA12 |
carbonic anhydrase XII |
chr12_-_106641728 | 5.63 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr11_-_6341844 | 5.53 |
ENST00000303927.3 |
PRKCDBP |
protein kinase C, delta binding protein |
chr12_+_52626898 | 5.43 |
ENST00000331817.5 |
KRT7 |
keratin 7 |
chr3_-_127542051 | 5.32 |
ENST00000398104.1 |
MGLL |
monoglyceride lipase |
chr9_-_21975038 | 5.27 |
ENST00000446177.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr3_-_127542021 | 5.11 |
ENST00000434178.2 |
MGLL |
monoglyceride lipase |
chr3_-_120170052 | 5.04 |
ENST00000295633.3 |
FSTL1 |
follistatin-like 1 |
chr18_+_21269404 | 4.82 |
ENST00000313654.9 |
LAMA3 |
laminin, alpha 3 |
chr18_+_61420169 | 4.79 |
ENST00000425392.1 ENST00000336429.2 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr9_-_21974820 | 4.72 |
ENST00000579122.1 ENST00000498124.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr1_-_225840747 | 4.64 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr6_+_83073952 | 4.58 |
ENST00000543496.1 |
TPBG |
trophoblast glycoprotein |
chrX_+_73641286 | 4.57 |
ENST00000587091.1 |
SLC16A2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
chr5_+_135385202 | 4.48 |
ENST00000514554.1 |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
chr6_+_7541845 | 4.43 |
ENST00000418664.2 |
DSP |
desmoplakin |
chr18_+_21269556 | 4.34 |
ENST00000399516.3 |
LAMA3 |
laminin, alpha 3 |
chr6_-_169654139 | 4.29 |
ENST00000366787.3 |
THBS2 |
thrombospondin 2 |
chr15_-_63674218 | 4.14 |
ENST00000178638.3 |
CA12 |
carbonic anhydrase XII |
chr18_-_21852143 | 4.01 |
ENST00000399443.3 |
OSBPL1A |
oxysterol binding protein-like 1A |
chr5_-_157002775 | 3.97 |
ENST00000257527.4 |
ADAM19 |
ADAM metallopeptidase domain 19 |
chr11_-_6341724 | 3.89 |
ENST00000530979.1 |
PRKCDBP |
protein kinase C, delta binding protein |
chr7_-_151574191 | 3.77 |
ENST00000287878.4 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr19_-_51456198 | 3.66 |
ENST00000594846.1 |
KLK5 |
kallikrein-related peptidase 5 |
chr17_+_70117153 | 3.61 |
ENST00000245479.2 |
SOX9 |
SRY (sex determining region Y)-box 9 |
chr15_-_71146480 | 3.47 |
ENST00000299213.8 |
LARP6 |
La ribonucleoprotein domain family, member 6 |
chr1_+_150480576 | 3.46 |
ENST00000346569.6 |
ECM1 |
extracellular matrix protein 1 |
chr1_-_32169920 | 3.38 |
ENST00000373672.3 ENST00000373668.3 |
COL16A1 |
collagen, type XVI, alpha 1 |
chr17_-_39674668 | 3.36 |
ENST00000393981.3 |
KRT15 |
keratin 15 |
chr8_+_26435359 | 3.35 |
ENST00000311151.5 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr9_-_21975088 | 3.35 |
ENST00000304494.5 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr1_-_32169761 | 3.35 |
ENST00000271069.6 |
COL16A1 |
collagen, type XVI, alpha 1 |
chr15_+_74218787 | 3.34 |
ENST00000261921.7 |
LOXL1 |
lysyl oxidase-like 1 |
chr3_-_127541679 | 3.33 |
ENST00000265052.5 |
MGLL |
monoglyceride lipase |
chr19_-_51487071 | 3.31 |
ENST00000391807.1 ENST00000593904.1 |
KLK7 |
kallikrein-related peptidase 7 |
chr7_+_32996997 | 3.29 |
ENST00000242209.4 ENST00000538336.1 ENST00000538443.1 |
FKBP9 |
FK506 binding protein 9, 63 kDa |
chr4_-_102268484 | 3.26 |
ENST00000394853.4 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr2_-_161350305 | 3.24 |
ENST00000348849.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr19_+_48216600 | 3.20 |
ENST00000263277.3 ENST00000538399.1 |
EHD2 |
EH-domain containing 2 |
chr1_+_20915409 | 3.19 |
ENST00000375071.3 |
CDA |
cytidine deaminase |
chr1_+_64059332 | 3.18 |
ENST00000540265.1 |
PGM1 |
phosphoglucomutase 1 |
chr1_+_150480551 | 3.14 |
ENST00000369049.4 ENST00000369047.4 |
ECM1 |
extracellular matrix protein 1 |
chr8_+_95653302 | 3.12 |
ENST00000423620.2 ENST00000433389.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr10_-_79397391 | 3.09 |
ENST00000286628.8 ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr3_+_105085734 | 3.09 |
ENST00000306107.5 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr19_+_16178317 | 3.08 |
ENST00000344824.6 ENST00000538887.1 |
TPM4 |
tropomyosin 4 |
chr6_-_10415470 | 3.06 |
ENST00000379604.2 ENST00000379613.3 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr3_-_149688655 | 3.01 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr3_+_105086056 | 3.00 |
ENST00000472644.2 |
ALCAM |
activated leukocyte cell adhesion molecule |
chr3_-_149688896 | 2.96 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chr5_-_175843524 | 2.95 |
ENST00000502877.1 |
CLTB |
clathrin, light chain B |
chr8_+_31497271 | 2.94 |
ENST00000520407.1 |
NRG1 |
neuregulin 1 |
chr2_-_158732340 | 2.91 |
ENST00000539637.1 ENST00000413751.1 ENST00000434821.1 ENST00000424669.1 |
ACVR1 |
activin A receptor, type I |
chr1_+_64058939 | 2.88 |
ENST00000371084.3 |
PGM1 |
phosphoglucomutase 1 |
chr19_-_50143452 | 2.87 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chr5_-_72744336 | 2.87 |
ENST00000499003.3 |
FOXD1 |
forkhead box D1 |
chr10_+_8096769 | 2.86 |
ENST00000346208.3 |
GATA3 |
GATA binding protein 3 |
chr16_+_86544113 | 2.84 |
ENST00000262426.4 |
FOXF1 |
forkhead box F1 |
chr8_+_95653427 | 2.83 |
ENST00000454170.2 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr8_+_95653373 | 2.81 |
ENST00000358397.5 |
ESRP1 |
epithelial splicing regulatory protein 1 |
chr10_-_17659357 | 2.73 |
ENST00000326961.6 ENST00000361271.3 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr1_-_153588765 | 2.72 |
ENST00000368701.1 ENST00000344616.2 |
S100A14 |
S100 calcium binding protein A14 |
chr1_-_153588334 | 2.70 |
ENST00000476873.1 |
S100A14 |
S100 calcium binding protein A14 |
chr10_+_89419370 | 2.69 |
ENST00000361175.4 ENST00000456849.1 |
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr9_-_35689900 | 2.66 |
ENST00000378300.5 ENST00000329305.2 ENST00000360958.2 |
TPM2 |
tropomyosin 2 (beta) |
chr13_-_110959478 | 2.60 |
ENST00000543140.1 ENST00000375820.4 |
COL4A1 |
collagen, type IV, alpha 1 |
chr5_-_175843569 | 2.59 |
ENST00000310418.4 ENST00000345807.2 |
CLTB |
clathrin, light chain B |
chr13_+_110959598 | 2.58 |
ENST00000360467.5 |
COL4A2 |
collagen, type IV, alpha 2 |
chr2_+_36582857 | 2.57 |
ENST00000280527.2 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
chr10_-_79397316 | 2.55 |
ENST00000372421.5 ENST00000457953.1 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr2_-_216300784 | 2.54 |
ENST00000421182.1 ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1 |
fibronectin 1 |
chr2_-_31361543 | 2.50 |
ENST00000349752.5 |
GALNT14 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr6_+_7541808 | 2.49 |
ENST00000379802.3 |
DSP |
desmoplakin |
chr3_-_149688502 | 2.47 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr10_-_79397202 | 2.45 |
ENST00000372437.1 ENST00000372408.2 ENST00000372403.4 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr10_-_79398250 | 2.44 |
ENST00000286627.5 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr4_+_88928777 | 2.44 |
ENST00000237596.2 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
chr15_-_52821070 | 2.38 |
ENST00000356338.6 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
chr2_-_169104651 | 2.37 |
ENST00000355999.4 |
STK39 |
serine threonine kinase 39 |
chr4_+_38869410 | 2.36 |
ENST00000358869.2 |
FAM114A1 |
family with sequence similarity 114, member A1 |
chr22_+_38093005 | 2.34 |
ENST00000406386.3 |
TRIOBP |
TRIO and F-actin binding protein |
chr7_-_47621736 | 2.32 |
ENST00000311160.9 |
TNS3 |
tensin 3 |
chr8_+_22446763 | 2.32 |
ENST00000450780.2 ENST00000430850.2 ENST00000447849.1 |
AC037459.4 |
Uncharacterized protein |
chr2_-_106015527 | 2.30 |
ENST00000344213.4 ENST00000358129.4 |
FHL2 |
four and a half LIM domains 2 |
chr2_-_106015491 | 2.29 |
ENST00000408995.1 ENST00000393353.3 ENST00000322142.8 |
FHL2 |
four and a half LIM domains 2 |
chr16_-_28550320 | 2.25 |
ENST00000395641.2 |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
chr2_-_161349909 | 2.22 |
ENST00000392753.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr3_-_45187843 | 2.22 |
ENST00000296129.1 ENST00000425231.2 |
CDCP1 |
CUB domain containing protein 1 |
chr4_-_7941596 | 2.22 |
ENST00000420658.1 ENST00000358461.2 |
AFAP1 |
actin filament associated protein 1 |
chr5_-_146833485 | 2.20 |
ENST00000398514.3 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr7_-_19157248 | 2.20 |
ENST00000242261.5 |
TWIST1 |
twist family bHLH transcription factor 1 |
chr15_-_52821247 | 2.18 |
ENST00000399231.3 ENST00000399233.2 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
chr10_-_17659234 | 2.16 |
ENST00000466335.1 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr17_+_73750699 | 2.15 |
ENST00000584939.1 |
ITGB4 |
integrin, beta 4 |
chr12_+_96588143 | 2.10 |
ENST00000228741.3 ENST00000547249.1 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr2_+_74120094 | 2.09 |
ENST00000409731.3 ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2 |
actin, gamma 2, smooth muscle, enteric |
chr12_-_89746173 | 2.06 |
ENST00000308385.6 |
DUSP6 |
dual specificity phosphatase 6 |
chr1_+_35220613 | 2.05 |
ENST00000338513.1 |
GJB5 |
gap junction protein, beta 5, 31.1kDa |
chr9_-_110251836 | 2.05 |
ENST00000374672.4 |
KLF4 |
Kruppel-like factor 4 (gut) |
chr1_+_158979792 | 2.04 |
ENST00000359709.3 ENST00000430894.2 |
IFI16 |
interferon, gamma-inducible protein 16 |
chr6_-_31324943 | 2.01 |
ENST00000412585.2 ENST00000434333.1 |
HLA-B |
major histocompatibility complex, class I, B |
chr3_+_135684515 | 2.00 |
ENST00000264977.3 ENST00000490467.1 |
PPP2R3A |
protein phosphatase 2, regulatory subunit B'', alpha |
chr8_+_26371763 | 2.00 |
ENST00000521913.1 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr1_+_64239657 | 1.98 |
ENST00000371080.1 ENST00000371079.1 |
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
chr11_+_32112431 | 1.96 |
ENST00000054950.3 |
RCN1 |
reticulocalbin 1, EF-hand calcium binding domain |
chr1_-_110933663 | 1.95 |
ENST00000369781.4 ENST00000541986.1 ENST00000369779.4 |
SLC16A4 |
solute carrier family 16, member 4 |
chr1_-_120612240 | 1.92 |
ENST00000256646.2 |
NOTCH2 |
notch 2 |
chr1_+_209848749 | 1.91 |
ENST00000367029.4 |
G0S2 |
G0/G1switch 2 |
chr1_-_110933611 | 1.88 |
ENST00000472422.2 ENST00000437429.2 |
SLC16A4 |
solute carrier family 16, member 4 |
chr19_-_45926739 | 1.88 |
ENST00000589381.1 ENST00000591636.1 ENST00000013807.5 ENST00000592023.1 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr8_+_31496809 | 1.85 |
ENST00000518104.1 ENST00000519301.1 |
NRG1 |
neuregulin 1 |
chr1_+_158979680 | 1.79 |
ENST00000368131.4 ENST00000340979.6 |
IFI16 |
interferon, gamma-inducible protein 16 |
chr10_+_8096631 | 1.78 |
ENST00000379328.3 |
GATA3 |
GATA binding protein 3 |
chr15_-_52821020 | 1.78 |
ENST00000553916.1 |
MYO5A |
myosin VA (heavy chain 12, myoxin) |
chrX_+_47444613 | 1.78 |
ENST00000445623.1 |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
chr6_-_80657292 | 1.76 |
ENST00000369816.4 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
chrX_+_107069063 | 1.76 |
ENST00000262843.6 |
MID2 |
midline 2 |
chr12_-_54813229 | 1.76 |
ENST00000293379.4 |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr1_+_158979686 | 1.75 |
ENST00000368132.3 ENST00000295809.7 |
IFI16 |
interferon, gamma-inducible protein 16 |
chr6_+_30848557 | 1.73 |
ENST00000460944.2 ENST00000324771.8 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
chr17_+_65373531 | 1.72 |
ENST00000580974.1 |
PITPNC1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr17_-_15587602 | 1.71 |
ENST00000416464.2 ENST00000578237.1 ENST00000581200.1 |
TRIM16 |
tripartite motif containing 16 |
chr11_+_844406 | 1.70 |
ENST00000397404.1 |
TSPAN4 |
tetraspanin 4 |
chr19_-_44174305 | 1.66 |
ENST00000601723.1 ENST00000339082.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr12_-_91573132 | 1.66 |
ENST00000550563.1 ENST00000546370.1 |
DCN |
decorin |
chr11_+_844067 | 1.64 |
ENST00000397406.1 ENST00000409543.2 ENST00000525201.1 |
TSPAN4 |
tetraspanin 4 |
chrX_-_68385354 | 1.64 |
ENST00000361478.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chr5_-_157002749 | 1.63 |
ENST00000517905.1 ENST00000430702.2 ENST00000394020.1 |
ADAM19 |
ADAM metallopeptidase domain 19 |
chr10_+_123872483 | 1.61 |
ENST00000369001.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr4_+_30721968 | 1.61 |
ENST00000361762.2 |
PCDH7 |
protocadherin 7 |
chr14_+_23775971 | 1.61 |
ENST00000250405.5 |
BCL2L2 |
BCL2-like 2 |
chr7_+_17338239 | 1.58 |
ENST00000242057.4 |
AHR |
aryl hydrocarbon receptor |
chr8_-_119124045 | 1.58 |
ENST00000378204.2 |
EXT1 |
exostosin glycosyltransferase 1 |
chr12_-_91573249 | 1.57 |
ENST00000550099.1 ENST00000546391.1 ENST00000551354.1 |
DCN |
decorin |
chr4_+_148402069 | 1.57 |
ENST00000358556.4 ENST00000339690.5 ENST00000511804.1 ENST00000324300.5 |
EDNRA |
endothelin receptor type A |
chrX_-_68385274 | 1.56 |
ENST00000374584.3 ENST00000590146.1 |
PJA1 |
praja ring finger 1, E3 ubiquitin protein ligase |
chrX_+_107683096 | 1.56 |
ENST00000328300.6 ENST00000361603.2 |
COL4A5 |
collagen, type IV, alpha 5 |
chr22_-_37915247 | 1.55 |
ENST00000251973.5 |
CARD10 |
caspase recruitment domain family, member 10 |
chr18_+_33877654 | 1.54 |
ENST00000257209.4 ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3 |
formin homology 2 domain containing 3 |
chr17_+_65374075 | 1.54 |
ENST00000581322.1 |
PITPNC1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
chrX_-_41782683 | 1.53 |
ENST00000378163.1 ENST00000378154.1 |
CASK |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
chr12_+_54332535 | 1.53 |
ENST00000243056.3 |
HOXC13 |
homeobox C13 |
chr17_-_7307358 | 1.53 |
ENST00000576017.1 ENST00000302422.3 ENST00000535512.1 |
TMEM256 TMEM256-PLSCR3 |
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
chr6_+_71998506 | 1.52 |
ENST00000370435.4 |
OGFRL1 |
opioid growth factor receptor-like 1 |
chr5_+_140767452 | 1.52 |
ENST00000519479.1 |
PCDHGB4 |
protocadherin gamma subfamily B, 4 |
chr12_-_85306594 | 1.51 |
ENST00000266682.5 |
SLC6A15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
chr14_-_27066960 | 1.51 |
ENST00000539517.2 |
NOVA1 |
neuro-oncological ventral antigen 1 |
chr12_+_57984965 | 1.51 |
ENST00000540759.2 ENST00000551772.1 ENST00000550465.1 ENST00000354947.5 |
PIP4K2C |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
chr8_+_32405785 | 1.50 |
ENST00000287842.3 |
NRG1 |
neuregulin 1 |
chr8_+_32405728 | 1.50 |
ENST00000523079.1 ENST00000338921.4 ENST00000356819.4 ENST00000287845.5 ENST00000341377.5 |
NRG1 |
neuregulin 1 |
chr4_-_90759440 | 1.49 |
ENST00000336904.3 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr19_-_45927622 | 1.48 |
ENST00000300853.3 ENST00000589165.1 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr6_+_32821924 | 1.47 |
ENST00000374859.2 ENST00000453265.2 |
PSMB9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
chr7_+_94023873 | 1.46 |
ENST00000297268.6 |
COL1A2 |
collagen, type I, alpha 2 |
chr16_+_57662138 | 1.45 |
ENST00000562414.1 ENST00000561969.1 ENST00000562631.1 ENST00000563445.1 ENST00000565338.1 ENST00000567702.1 |
GPR56 |
G protein-coupled receptor 56 |
chr19_-_44174330 | 1.45 |
ENST00000340093.3 |
PLAUR |
plasminogen activator, urokinase receptor |
chr4_-_84256024 | 1.45 |
ENST00000311412.5 |
HPSE |
heparanase |
chr3_+_110790590 | 1.44 |
ENST00000485303.1 |
PVRL3 |
poliovirus receptor-related 3 |
chr22_-_36424458 | 1.44 |
ENST00000438146.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr8_-_145018080 | 1.43 |
ENST00000354589.3 |
PLEC |
plectin |
chr12_-_124457257 | 1.43 |
ENST00000545891.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr1_-_33168336 | 1.42 |
ENST00000373484.3 |
SYNC |
syncoilin, intermediate filament protein |
chr3_-_46735155 | 1.41 |
ENST00000318962.4 |
ALS2CL |
ALS2 C-terminal like |
chr12_-_49319265 | 1.40 |
ENST00000552878.1 ENST00000453172.2 |
FKBP11 |
FK506 binding protein 11, 19 kDa |
chr4_+_99182593 | 1.40 |
ENST00000508213.1 ENST00000408927.3 ENST00000514122.1 ENST00000453712.2 ENST00000511212.1 ENST00000408900.3 ENST00000339360.5 |
RAP1GDS1 |
RAP1, GTP-GDP dissociation stimulator 1 |
chr6_-_10415218 | 1.39 |
ENST00000466073.1 ENST00000498450.1 |
TFAP2A |
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr7_+_55086703 | 1.38 |
ENST00000455089.1 ENST00000342916.3 ENST00000344576.2 ENST00000420316.2 |
EGFR |
epidermal growth factor receptor |
chr9_+_116298778 | 1.37 |
ENST00000462143.1 |
RGS3 |
regulator of G-protein signaling 3 |
chr19_-_45953983 | 1.37 |
ENST00000592083.1 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr3_-_13921594 | 1.37 |
ENST00000285018.4 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
chr1_+_155293702 | 1.35 |
ENST00000368347.4 |
RUSC1 |
RUN and SH3 domain containing 1 |
chr14_+_75746340 | 1.34 |
ENST00000555686.1 ENST00000555672.1 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
chr6_-_3752222 | 1.34 |
ENST00000380283.4 |
PXDC1 |
PX domain containing 1 |
chr16_+_57662419 | 1.34 |
ENST00000388812.4 ENST00000538815.1 ENST00000456916.1 ENST00000567154.1 ENST00000388813.5 ENST00000562558.1 ENST00000566271.2 |
GPR56 |
G protein-coupled receptor 56 |
chr19_-_45927097 | 1.33 |
ENST00000340192.7 |
ERCC1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) |
chr22_-_36236265 | 1.33 |
ENST00000414461.2 ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr4_-_141677267 | 1.33 |
ENST00000442267.2 |
TBC1D9 |
TBC1 domain family, member 9 (with GRAM domain) |
chr12_-_91573316 | 1.32 |
ENST00000393155.1 |
DCN |
decorin |
chr4_-_84255935 | 1.31 |
ENST00000513463.1 |
HPSE |
heparanase |
chr22_-_36236623 | 1.28 |
ENST00000405409.2 |
RBFOX2 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr1_-_6321035 | 1.28 |
ENST00000377893.2 |
GPR153 |
G protein-coupled receptor 153 |
chr6_-_84140757 | 1.27 |
ENST00000541327.1 ENST00000369705.3 ENST00000543031.1 |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr15_+_81071684 | 1.27 |
ENST00000220244.3 ENST00000394685.3 ENST00000356249.5 |
KIAA1199 |
KIAA1199 |
chrX_-_107682702 | 1.25 |
ENST00000372216.4 |
COL4A6 |
collagen, type IV, alpha 6 |
chr10_-_79397479 | 1.25 |
ENST00000404771.3 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr12_+_48513009 | 1.24 |
ENST00000359794.5 ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM |
phosphofructokinase, muscle |
chr20_+_17550489 | 1.23 |
ENST00000246069.7 |
DSTN |
destrin (actin depolymerizing factor) |
chr15_-_52472078 | 1.23 |
ENST00000396335.4 ENST00000560116.1 ENST00000358784.7 |
GNB5 |
guanine nucleotide binding protein (G protein), beta 5 |
chr14_+_71374122 | 1.21 |
ENST00000304743.2 ENST00000238570.5 |
PCNX |
pecanex homolog (Drosophila) |
chr6_+_151561506 | 1.20 |
ENST00000253332.1 |
AKAP12 |
A kinase (PRKA) anchor protein 12 |
chr10_-_79397740 | 1.20 |
ENST00000372440.1 ENST00000480683.1 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr12_-_56120865 | 1.19 |
ENST00000548898.1 ENST00000552067.1 |
CD63 |
CD63 molecule |
chr4_-_22517620 | 1.18 |
ENST00000502482.1 ENST00000334304.5 |
GPR125 |
G protein-coupled receptor 125 |
chr12_-_124457371 | 1.18 |
ENST00000238156.3 ENST00000545037.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr3_+_189507432 | 1.18 |
ENST00000354600.5 |
TP63 |
tumor protein p63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 12.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
4.2 | 12.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
2.3 | 4.6 | GO:2000683 | regulation of cellular response to X-ray(GO:2000683) |
2.0 | 13.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.6 | 9.8 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
1.5 | 8.8 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
1.3 | 14.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
1.2 | 3.6 | GO:0060018 | astrocyte fate commitment(GO:0060018) retinal rod cell differentiation(GO:0060221) |
1.2 | 4.8 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
1.2 | 13.0 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
1.2 | 7.0 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.2 | 8.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.1 | 8.0 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
1.1 | 4.4 | GO:0003409 | optic cup structural organization(GO:0003409) |
1.1 | 3.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.0 | 6.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.0 | 2.9 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.9 | 2.8 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.9 | 4.6 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.9 | 3.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 2.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.8 | 6.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.8 | 0.8 | GO:0072278 | metanephric comma-shaped body morphogenesis(GO:0072278) |
0.8 | 2.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.8 | 1.6 | GO:0060066 | oviduct development(GO:0060066) |
0.8 | 3.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.7 | 2.2 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.7 | 8.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.7 | 4.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.7 | 2.0 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
0.7 | 8.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 4.0 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 2.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 1.6 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.5 | 2.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 2.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 2.0 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 2.3 | GO:0030047 | actin modification(GO:0030047) |
0.5 | 6.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.5 | 1.4 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.4 | 12.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 2.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.4 | 1.6 | GO:0048749 | compound eye development(GO:0048749) |
0.4 | 4.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.4 | 4.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.4 | 2.9 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.7 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.3 | 3.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.3 | 1.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.3 | 1.0 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
0.3 | 1.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 1.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 0.3 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.3 | 0.9 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) regulation of bundle of His cell action potential(GO:0098905) |
0.3 | 1.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.8 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.3 | 1.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.3 | 1.2 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.3 | 1.8 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 6.6 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.3 | 0.8 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.3 | 0.8 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.3 | 1.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.7 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 2.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 2.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.2 | 0.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.9 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 1.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 6.1 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.2 | 4.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 1.5 | GO:0035878 | nail development(GO:0035878) |
0.2 | 2.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.2 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.2 | 5.6 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 1.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 1.1 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
0.2 | 0.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 0.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 2.0 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 0.6 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.2 | 0.6 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.2 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.7 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 3.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.2 | 1.7 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 0.2 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 1.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.2 | 1.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 1.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.8 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.2 | 0.8 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.2 | 1.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 3.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.6 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 5.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
0.1 | 0.1 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 1.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 2.3 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 2.3 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 2.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.4 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.6 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.1 | 0.6 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 2.0 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 5.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.7 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) |
0.1 | 1.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.9 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.1 | 0.4 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.9 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 | 0.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 4.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.5 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 2.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 2.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 7.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 1.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 0.3 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 1.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.6 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.1 | 2.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 8.7 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
0.1 | 0.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 0.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 6.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 4.0 | GO:0035904 | aorta development(GO:0035904) |
0.1 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 1.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 1.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 3.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.3 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 4.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.4 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.5 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.1 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 1.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.1 | 0.2 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 1.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.1 | 0.3 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 6.8 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.9 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 3.5 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.0 | 0.8 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.6 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.4 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 2.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 1.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.5 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
0.0 | 0.5 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.0 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 1.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.4 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 3.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 1.7 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.0 | 0.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.0 | 1.0 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.6 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.2 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.1 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:1905232 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) cellular response to L-glutamate(GO:1905232) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.1 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.0 | 0.1 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.0 | 1.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 11.3 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 1.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 1.2 | GO:0045453 | bone resorption(GO:0045453) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.9 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 2.5 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.8 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 1.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.0 | 3.5 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.4 | GO:0048512 | circadian behavior(GO:0048512) |
0.0 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.0 | 0.1 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
0.0 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.7 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.8 | GO:0032392 | DNA geometric change(GO:0032392) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 8.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.6 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.5 | 13.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 7.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.4 | 6.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 14.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 7.9 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 6.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 7.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 13.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 6.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 14.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 8.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 5.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 3.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 5.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 6.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 3.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 7.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 13.9 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 3.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.6 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 7.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 3.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.0 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.9 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 2.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 7.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 5.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 6.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 4.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 6.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 1.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.5 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.4 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 4.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.7 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.0 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 14.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.9 | 11.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.8 | 5.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.2 | 12.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 13.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.0 | 3.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.0 | 6.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 2.7 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.9 | 6.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.8 | 14.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.8 | 2.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.8 | 7.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 6.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.7 | 2.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.7 | 2.8 | GO:0030305 | heparanase activity(GO:0030305) |
0.6 | 7.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.6 | 2.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.6 | 4.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 1.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.5 | 1.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.5 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 3.0 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.4 | 7.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 3.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 2.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.4 | 3.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.4 | 1.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.4 | 1.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 3.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.4 | 4.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 2.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 3.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.3 | 2.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 1.0 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.3 | 0.7 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 1.9 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.3 | 1.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.3 | 0.9 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.3 | 1.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.3 | 1.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.3 | 1.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 1.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 0.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 19.8 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 2.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.3 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.2 | 2.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 3.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.2 | 8.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 7.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 4.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.5 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 1.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.8 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 2.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 1.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.9 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 1.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.6 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 16.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 3.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.3 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.1 | 2.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.3 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 6.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 2.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 5.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 6.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 3.4 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 2.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 13.8 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 5.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.4 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 1.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.0 | 1.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.2 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.0 | 0.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 3.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.3 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 1.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.4 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 1.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.0 | 1.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 17.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0019828 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0009374 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 4.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.0 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) kainate selective glutamate receptor activity(GO:0015277) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.9 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 5.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 4.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.9 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 12.8 | GO:0005955 | calcineurin complex(GO:0005955) |
1.2 | 13.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.1 | 9.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 8.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
1.0 | 7.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.9 | 6.1 | GO:0070522 | nucleotide-excision repair factor 1 complex(GO:0000110) ERCC4-ERCC1 complex(GO:0070522) |
0.8 | 6.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.8 | 6.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 3.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.5 | 7.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.5 | 6.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 1.8 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 5.6 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 2.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 1.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 7.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 4.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 3.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 2.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 4.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 1.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.3 | 1.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.3 | 1.6 | GO:0032449 | CBM complex(GO:0032449) |
0.3 | 5.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 1.1 | GO:0031673 | H zone(GO:0031673) |
0.3 | 1.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.2 | 0.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) integrin alphav-beta8 complex(GO:0034686) |
0.2 | 1.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 7.0 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 3.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.8 | GO:1990075 | kinesin II complex(GO:0016939) periciliary membrane compartment(GO:1990075) |
0.2 | 18.1 | GO:0005604 | basement membrane(GO:0005604) |
0.2 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 2.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 5.5 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.8 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 2.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 4.7 | GO:0031430 | M band(GO:0031430) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 9.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 4.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.1 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 9.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 11.0 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.8 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.1 | 1.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 3.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 2.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 2.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 2.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 3.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 1.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 4.7 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 24.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 14.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 2.7 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 9.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.8 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 2.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.5 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 2.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.7 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 5.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 1.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.8 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 11.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 11.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 15.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.3 | 17.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 9.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 6.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 10.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 5.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 11.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 4.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 6.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 11.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.6 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 4.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 3.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 13.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 1.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 2.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 7.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |